Abstract

Lung-sparing surgery for malignant pleural mesothelioma (MPM) is associated with a difficult and prolonged recovery due to the extensive nature of the procedure. For a select group of patients, prolonged survival rates have been reported. A clear understanding of which patients will benefit from lung-sparing surgery is currently unknown. Despite having favorable tumor histologies, limited tumor burden and being deemed physically fit for surgery, some patients will still experience increased morbidity and/or mortality.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call